Muraglitazar is an agonist of dual peroxisome proliferator-activated receptor (PPAR). It shows hypoglycemic activity and used in the treatment of patients with type 2 diabetes. Reference standards of Muraglitazar API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
